Add-on Acquisition • Healthcare Services

AngioSoma Acquires Diabetes Relief

On December 14, 2018, AngioSoma acquired healthcare services company Diabetes Relief

Acquisition Context

This is AngioSoma’s 1st transaction in the Healthcare Services sector.
This is AngioSoma’s 1st transaction in the United States.
This is AngioSoma’s 1st transaction in Texas.

Explore All 4611 Add-on Acquisition Healthcare Services Deals - Search the Database Free

M&A Deal Summary
Date	December 14, 2018
Target	Diabetes Relief
Sector	Healthcare Services
Buyer(s)	AngioSoma
Deal Type	Add-on Acquisition

Target Company

Diabetes Relief

Houston, Texas, United States

Diabetes Relief LLC is a provider of medical facilities for the treatment of metabolic disorder, specializing in diabetes, for the use of patented protocols, processes, and intellectual property. Diabetes Relief is based in Houston, Texas.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

AngioSoma

Houston, Texas, United States

Category	Company
Sector	Medical Products

DESCRIPTION

AngioSoma, Inc. is a provider of supplements for improving the mental and physical well-being of men and women, underSomaceuticals™ common identity. AngioSoma is based in Houston, Texas.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Healthcare Services	1 of 1
Type: Add-on Acquisition	1 of 1
State: Texas	1 of 1
Country: United States	1 of 1
Year: 2018	1 of 1

Explore Related M&A Activity

Healthcare Services M&A - Add-on Acquisition M&A Deals - Texas M&A - United States M&A - 2018 M&A